- Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
-
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.
- -
-
Paragraph 1038; 1039
(2015/08/04)
-
- NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
-
The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.
- -
-
Page/Page column 122; 123
(2015/09/23)
-
- NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
-
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R6, X and Y are as described in the description and in the claims, as well as or pharmaceutically acceptable salts, or enantiomers, or diastereomers thereof. The invention also contains compositions including the compounds and methods of using the compounds.
- -
-
Page/Page column 53
(2016/04/26)
-
- Indoloisoquinolines. Syntheses, Steroid Hormone Receptor Binding Affinities, and Cytostatic Activity
-
A number of acetoxy-substituted 5,6-dihydroindoloisoquinolines were synthesized and tested for binding affinity for steroid hormone receptors.All of the derivatives bind to the estrogen receptor with RBA values ranging from 1.5 to 17 (17β-estradiol
- Ambros, Reinhard,Schneider, Martin R.,Angerer, Silvia von
-
p. 153 - 160
(2007/10/02)
-